合成了一系列的4-氨基-5-乙烯基-3(2H)-哒嗪酮及其类似物,并在小鼠腹部收缩模型中评估了它们的抗伤害作用。几种新化合物的ED(50)值在6-20mg / kg / sc范围内,并证明能够完全保护所有处理过的动物免受30 mg / kg / sc的有害刺激的影响。SAR研究证实,二嗪系统第4位的氨基或取代的氨基官能团和第5位的乙烯基具有重要的作用。
4,5-Functionalized 6-phenyl-3(2H)-pyridazinones: synthesis and evaluation of antinociceptive activity
摘要:
A series of 2-substituted 4,5-functionalized 6-phenyl-3(2H)-pyridazinones were synthesized and their antinociceptive activities were evaluated in the mouse abdominal constriction model. Single dose studies showed that compounds 11, 18a and 23 were more active than the reference drug, Emorfazone, in inhibiting the effects of the noxious chemical stimulus, p-phenylquinone. Subsequent dose-response studies revealed 18a to be almost seven-fold more potent than Emorfazone.
4-Amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: Synthesis, SARs, and preliminary studies on the mechanism of action
作者:Claudia Vergelli、Maria Paola Giovannoni、Stefano Pieretti、Amalia Di Giannuario、Vittorio Dal Piaz、Pierfrancesco Biagini、Claudio Biancalani、Alessia Graziano、Nicoletta Cesari
DOI:10.1016/j.bmc.2007.05.035
日期:2007.8
A series of 4-amino-5-vinyl-3(2H)-pyridazinones and analogues were synthesized and their antinociceptive effect was evaluated in the mouse abdominal constriction model. Several of the novel compounds showed ED(50) values in the range 6-20mg/kg/sc and demonstrated to be able to completely protect all the treated animals from the effect of the noxious stimulus at 30 mg/kg/sc. SAR studies confirmed the
合成了一系列的4-氨基-5-乙烯基-3(2H)-哒嗪酮及其类似物,并在小鼠腹部收缩模型中评估了它们的抗伤害作用。几种新化合物的ED(50)值在6-20mg / kg / sc范围内,并证明能够完全保护所有处理过的动物免受30 mg / kg / sc的有害刺激的影响。SAR研究证实,二嗪系统第4位的氨基或取代的氨基官能团和第5位的乙烯基具有重要的作用。
4,5-Functionalized 6-phenyl-3(2H)-pyridazinones: synthesis and evaluation of antinociceptive activity
作者:V Dal Piaz、MP Giovannoni、G Ciciani、D Barlocco、G Giardina、G Petrone、GD Clarke
DOI:10.1016/s0223-5234(96)80008-0
日期:1996.1
A series of 2-substituted 4,5-functionalized 6-phenyl-3(2H)-pyridazinones were synthesized and their antinociceptive activities were evaluated in the mouse abdominal constriction model. Single dose studies showed that compounds 11, 18a and 23 were more active than the reference drug, Emorfazone, in inhibiting the effects of the noxious chemical stimulus, p-phenylquinone. Subsequent dose-response studies revealed 18a to be almost seven-fold more potent than Emorfazone.